SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy

Kwang Youn Kim, Hyun Jun Jang, Yong Ryul Yang, Kwang Il Park, Jeong Kon Seo, Il Woo Shin, Tae Il Jeon, Soon Cheol Ahn, Pann Ghill Suh, Timothy Osborne, Young Kyo Seo

Research output: Contribution to journalArticle

Abstract

Dysregulated autophagy is associated with steatosis and non-alcoholic fatty liver disease (NAFLD), however the mechanisms connecting them remain poorly understand. Here, we show that co-administration of lovastatin and ezetimibe (L/E) significantly reverses hepatic triglyceride accumulation concomitant with an increase in SREBP-2 driven autophagy in mice fed a high-fat diet (HFD). We further show that the statin mediated increase in SREBP-2 directly activates expression of patatin-like phospholipase domain-containing enzyme 8 (PNPLA8) gene, and PNPLA8 associates with autophagosomes and is associated with a decrease in cellular triglyceride. Moreover, we show that over-expression of PNPLA8 dramatically decreases hepatic steatosis through increased autophagy in hepatocytes of HFD-fed mice. Live-cell imaging analyses also reveal that PNPLA8 dynamically interacts with LC3 and we suggest that the SREBP-2/PNPLA8 axis represents a novel regulatory mechanism for lipid homeostasis. These data provide a possible mechanism for the reported beneficial effects of statins for decreasing hepatic triglyceride levels in NAFLD patients.

Original languageEnglish (US)
Article number35732
JournalScientific Reports
Volume6
DOIs
StatePublished - Oct 21 2016
Externally publishedYes

Fingerprint

Phospholipases
Autophagy
Enzymes
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Triglycerides
High Fat Diet
Liver
Lovastatin
Hepatocytes
Homeostasis
Non-alcoholic Fatty Liver Disease
Lipids
Genes

ASJC Scopus subject areas

  • General

Cite this

Kim, K. Y., Jang, H. J., Yang, Y. R., Park, K. I., Seo, J. K., Shin, I. W., ... Seo, Y. K. (2016). SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy. Scientific Reports, 6, [35732]. https://doi.org/10.1038/srep35732

SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy. / Kim, Kwang Youn; Jang, Hyun Jun; Yang, Yong Ryul; Park, Kwang Il; Seo, Jeong Kon; Shin, Il Woo; Jeon, Tae Il; Ahn, Soon Cheol; Suh, Pann Ghill; Osborne, Timothy; Seo, Young Kyo.

In: Scientific Reports, Vol. 6, 35732, 21.10.2016.

Research output: Contribution to journalArticle

Kim, KY, Jang, HJ, Yang, YR, Park, KI, Seo, JK, Shin, IW, Jeon, TI, Ahn, SC, Suh, PG, Osborne, T & Seo, YK 2016, 'SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy', Scientific Reports, vol. 6, 35732. https://doi.org/10.1038/srep35732
Kim, Kwang Youn ; Jang, Hyun Jun ; Yang, Yong Ryul ; Park, Kwang Il ; Seo, Jeong Kon ; Shin, Il Woo ; Jeon, Tae Il ; Ahn, Soon Cheol ; Suh, Pann Ghill ; Osborne, Timothy ; Seo, Young Kyo. / SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy. In: Scientific Reports. 2016 ; Vol. 6.
@article{6d1f4a9675d644df9c460c7a109d01d5,
title = "SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy",
abstract = "Dysregulated autophagy is associated with steatosis and non-alcoholic fatty liver disease (NAFLD), however the mechanisms connecting them remain poorly understand. Here, we show that co-administration of lovastatin and ezetimibe (L/E) significantly reverses hepatic triglyceride accumulation concomitant with an increase in SREBP-2 driven autophagy in mice fed a high-fat diet (HFD). We further show that the statin mediated increase in SREBP-2 directly activates expression of patatin-like phospholipase domain-containing enzyme 8 (PNPLA8) gene, and PNPLA8 associates with autophagosomes and is associated with a decrease in cellular triglyceride. Moreover, we show that over-expression of PNPLA8 dramatically decreases hepatic steatosis through increased autophagy in hepatocytes of HFD-fed mice. Live-cell imaging analyses also reveal that PNPLA8 dynamically interacts with LC3 and we suggest that the SREBP-2/PNPLA8 axis represents a novel regulatory mechanism for lipid homeostasis. These data provide a possible mechanism for the reported beneficial effects of statins for decreasing hepatic triglyceride levels in NAFLD patients.",
author = "Kim, {Kwang Youn} and Jang, {Hyun Jun} and Yang, {Yong Ryul} and Park, {Kwang Il} and Seo, {Jeong Kon} and Shin, {Il Woo} and Jeon, {Tae Il} and Ahn, {Soon Cheol} and Suh, {Pann Ghill} and Timothy Osborne and Seo, {Young Kyo}",
year = "2016",
month = "10",
day = "21",
doi = "10.1038/srep35732",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy

AU - Kim, Kwang Youn

AU - Jang, Hyun Jun

AU - Yang, Yong Ryul

AU - Park, Kwang Il

AU - Seo, Jeong Kon

AU - Shin, Il Woo

AU - Jeon, Tae Il

AU - Ahn, Soon Cheol

AU - Suh, Pann Ghill

AU - Osborne, Timothy

AU - Seo, Young Kyo

PY - 2016/10/21

Y1 - 2016/10/21

N2 - Dysregulated autophagy is associated with steatosis and non-alcoholic fatty liver disease (NAFLD), however the mechanisms connecting them remain poorly understand. Here, we show that co-administration of lovastatin and ezetimibe (L/E) significantly reverses hepatic triglyceride accumulation concomitant with an increase in SREBP-2 driven autophagy in mice fed a high-fat diet (HFD). We further show that the statin mediated increase in SREBP-2 directly activates expression of patatin-like phospholipase domain-containing enzyme 8 (PNPLA8) gene, and PNPLA8 associates with autophagosomes and is associated with a decrease in cellular triglyceride. Moreover, we show that over-expression of PNPLA8 dramatically decreases hepatic steatosis through increased autophagy in hepatocytes of HFD-fed mice. Live-cell imaging analyses also reveal that PNPLA8 dynamically interacts with LC3 and we suggest that the SREBP-2/PNPLA8 axis represents a novel regulatory mechanism for lipid homeostasis. These data provide a possible mechanism for the reported beneficial effects of statins for decreasing hepatic triglyceride levels in NAFLD patients.

AB - Dysregulated autophagy is associated with steatosis and non-alcoholic fatty liver disease (NAFLD), however the mechanisms connecting them remain poorly understand. Here, we show that co-administration of lovastatin and ezetimibe (L/E) significantly reverses hepatic triglyceride accumulation concomitant with an increase in SREBP-2 driven autophagy in mice fed a high-fat diet (HFD). We further show that the statin mediated increase in SREBP-2 directly activates expression of patatin-like phospholipase domain-containing enzyme 8 (PNPLA8) gene, and PNPLA8 associates with autophagosomes and is associated with a decrease in cellular triglyceride. Moreover, we show that over-expression of PNPLA8 dramatically decreases hepatic steatosis through increased autophagy in hepatocytes of HFD-fed mice. Live-cell imaging analyses also reveal that PNPLA8 dynamically interacts with LC3 and we suggest that the SREBP-2/PNPLA8 axis represents a novel regulatory mechanism for lipid homeostasis. These data provide a possible mechanism for the reported beneficial effects of statins for decreasing hepatic triglyceride levels in NAFLD patients.

UR - http://www.scopus.com/inward/record.url?scp=84992375332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992375332&partnerID=8YFLogxK

U2 - 10.1038/srep35732

DO - 10.1038/srep35732

M3 - Article

C2 - 27767079

AN - SCOPUS:84992375332

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 35732

ER -